Stock Suspensions/Halts Friday, February 13, 2015 05:12:50

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Stock Suspensions/Halts Friday, February 13, 2015 05:12:50 AM

Effective Date Symbol Company Name Security Type Venue Status
Feb 12, 2015 STADF St Andrew Goldfields Ltd Ordinary Shares OTC Link Halted
Feb 12, 2015 LVGBF OVIVO INC Ordinary Shares Grey Market Halted
Feb 12, 2015 LVGAF OVIVO INC Ordinary Shares Grey Market Halted
Feb 12, 2015 LSLCF Lachlan Star Ltd. Ordinary Shares Grey Market Halted
Feb 12, 2015 GALEF Wolf Resource Development Corp. Ordinary Shares Grey Market Halted
Feb 12, 2015 FTMDF Fortune Minerals Limited Ordinary Shares OTC Link Halted
Feb 12, 2015 ERDCF Erdene Resource Development Corp. Ordinary Shares OTC Link Halted
Feb 12, 2015 AOIFF Africa Oil Corp. Ordinary Shares OTC Link Halted
Feb 11, 2015 ZNWAA Zion Oil & Gas, Inc. Nasdaq Halted
Feb 11, 2015 TAOIF TAG Oil Ltd. Ordinary Shares OTC Link Halted
Feb 11, 2015 PFGY Perfectenergy International Ltd. Common Stock Grey Market Revoked
Feb 11, 2015 BRLGF Brilliant Resources Inc. Ordinary Shares Grey Market Halted
Feb 10, 2015 UULFF Expedition Mining Inc Ordinary Shares Grey Market Halted
Feb 10, 2015 PVTTF Pivotal Therapeutics Inc Ordinary Shares OTC Link Halted
Feb 10, 2015 PME Pingtan Marine Enterprise Ltd. Nasdaq Halted
Feb 10, 2015 NICK Nicholas Financial, Inc. Common Stock Nasdaq Halted
Feb 10, 2015 IDAS International Datacasting Corporation Common Stock Grey Market Halted
Feb 10, 2015 ICGQF Integra Gold Corp. Ordinary Shares OTC Link Halted
Feb 10, 2015 FSRV FirstService Corporation Common Stock Nasdaq Halted
Feb 9, 2015 PZB Merrill Lynch Depositor, Inc. Preferred Stock NYSE Halted
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading